Cite
Euro HYP-1: European multicenter, randomized, phase III clinical trial of therapeutic hypothermia plus best medical treatment vs. best medical treatment alone for acute ischemic stroke.
MLA
Worp, H.Bart, et al. “Euro HYP-1: European Multicenter, Randomized, Phase III Clinical Trial of Therapeutic Hypothermia plus Best Medical Treatment vs. Best Medical Treatment Alone for Acute Ischemic Stroke.” International Journal of Stroke, vol. 9, no. 5, July 2014, pp. 642–45. EBSCOhost, https://doi.org/10.1111/ijs.12294.
APA
Worp, H. B., Macleod, M. R., Bath, P. M. W., Demotes, J., Durand-Zaleski, I., Gebhardt, B., Gluud, C., Kollmar, R., Krieger, D. W., Lees, K. R., Molina, C., Montaner, J., Roine, R. O., Petersson, J., Staykov, D., Szabo, I., Wardlaw, J. M., & Schwab, S. (2014). Euro HYP-1: European multicenter, randomized, phase III clinical trial of therapeutic hypothermia plus best medical treatment vs. best medical treatment alone for acute ischemic stroke. International Journal of Stroke, 9(5), 642–645. https://doi.org/10.1111/ijs.12294
Chicago
Worp, H. Bart, Malcolm R. Macleod, Philip M. W. Bath, Jacques Demotes, Isabelle Durand-Zaleski, Bernd Gebhardt, Christian Gluud, et al. 2014. “Euro HYP-1: European Multicenter, Randomized, Phase III Clinical Trial of Therapeutic Hypothermia plus Best Medical Treatment vs. Best Medical Treatment Alone for Acute Ischemic Stroke.” International Journal of Stroke 9 (5): 642–45. doi:10.1111/ijs.12294.